From: The virulence phenotypes and molecular epidemiological characteristics of Vibrio fluvialis in China
Antibiotic | Breakpoints (mg/ml) | Resistance | Sensitivity | |
---|---|---|---|---|
 |  | R (%) | I (%) | S (%) |
Ampicillin | S<=8 I=16 R>=32a | 12 (27.3) | 8 (18.2) | 24 (54.5) |
Amoxicillin/Clavulanic acid | S<=8/4 I=16/8 R>=32/16b | 10 (22.7) | 7 (15.9) | 27 (61.4) |
Cefotaxime | S<=1 I=2 R>=4b | 1 (2.3) | 6 (13.6) | 37 (84.1) |
Ceftriaxone | S<=1 I=2 R>=4b | 1 (2.3) | 6 (13.6) | 37 (84.1) |
Ceftazidime | S<=4 I=8 R>=16b | 0 (0) | 0 (0) | 44 (100) |
Chloramphenicol | S<=8 I=16 R>=32a | 0 (0) | 0 (0) | 44 (100) |
Ciprofloxacin | S<=1 I=2 R>=4b | 0 (0) | 0 (0) | 44 (100) |
Gentamicin | S<=4 I=8 R>=16b | 0 (0) | 0 (0) | 44 (100) |
Nalidixic acid | S<=16 R>=32b | 0 (0) | - | 44 (100) |
Streptomycin | S<16 R>=16d | 1 (2.3) | - | 43 (97.7) |
Sulfamethoxazole | S<=256 R>=512a | 11 (25.0) | - | 33 (75.0) |
Trimethoprim | S<=8 R>=16b | 0 (0) | - | 44 (100) |
Co-trimoxazole | S<=2/38 R>=4/76a | 0 (0) | - | 44 (100) |
Tetracycline | S<=4 I=8 R>=16a | 1 (2.3) | 0 (0) | 43 (97.7) |
Azithromycin | S<=2 I=4 R>=8c | 12 (27.3) | 5 (11.4) | 27 (61.3) |